Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.
The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs). The Company began the journey by focusing on import and registration of vital pesticide molecules. It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. After successful registration, it marketed these molecules both as technical and as value added end use formulations for both domestic manufacturers and MNCs.
In 2002, Company expanded from the sale of technical to companies, to establish its own manufacturing plant for formulations in December 2021, located in Dahej, Gujarat. From this manufacturing facility, it produce and sell bulk formulations, branded products (own brand products), and export them to customers. Domestically, it market the own branded products across states such as Punjab, Har ...yana, Rajasthan, Uttar Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and Telangana through a well-established dealer network. Internationally, it export the products to countries including the Dominican Republic, Turkey, Egypt, and the UAE.
The Company introduced Norwegian seaweed extract based Bio-stimulants formulations. The expansion of bio-products in agriculture is a critical strategy to meet the growing demand for sustainable and eco-friendly agricultural solutions. Company incorporated a subsidiary in UAE in the name of 'Mahamaya Lifesciences FZE' to further promote the import and export operations in 2017.
The Company began construction of factory in Dahej, Gujarat in FY 2018 and completed it after getting the license to manufacture insecticides from the Govt of Gujarat in FY 2022.
The Company came up with the initial public offer of 61,78,800 Equity Shares of Rs 10/- each by raising Rs 70.44 Crore consisting a fresh issue of
56,38,800 Equity Shares aggregating to Rs 64.28 crores and the offer for sale of 5,40,000 Equity Shares aggregating to Rs 6.15 crores in November, 2025.
FAQs on Mahamaya Lifesciences Ltd
1. Can I buy Mahamaya Lifesciences Ltd from PL Capital? ›
Yes, you can invest in Mahamaya Lifesciences Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Mahamaya Lifesciences Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Mahamaya Lifesciences Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Mahamaya Lifesciences Ltd pay dividends? ›
Mahamaya Lifesciences Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Mahamaya Lifesciences Ltd ? ›
As of
19-Feb-2026 , 16:01:53 the share price for Mahamaya Lifesciences Ltd. is ₹ 177.1 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Mahamaya Lifesciences Ltd ? ›
The 52-week high and low of Mahamaya Lifesciences Ltd share price is ₹ 111 - ₹ 205.05 as of
19-Feb-2026 , 16:01:53 .
